Mahkam Zanganeh, Co-Chief Executive Officer at Summit Therapeutics, bought SMMT on Jun 12, 2026

Data as of Oct 16

▲ BUY$50M3,810,000 shares at $13.12Mahkam Zanganeh Co-Chief Executive OfficerSMMT Summit Therapeutics Inc.

Watch SMMT

Traded: Jun 12, 2026
Disclosed: Jun 12, 2026
Filed: The same day

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

SMMTSimilar stocks (XLV — its sector index fund), rebased to SMMT's price on the disclosure day

SMMT since disclosure

+4.4%

Similar stocks (XLV) since disclosure

+14.9%

XLV — its sector index fund

Change in closing price from Jun 12, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on SMMT →